Supratentorial intracerebral hemorrhage (ICH) accounts for 10-15% of all strokes and results in significant morbidity and mortality. Standard of care involves supportive therapy to ameliorate secondary injury. Prior randomized controlled trials have suggested improved survival following minimally invasive clot evacuation.
The ENRICH Trial evaluated a Minimally Invasive trans-sulcal, Parafascicular Surgery (MIPS) approach. The trial conducted a multicenter, two-arm, randomized, Bayesian adaptive comparative-effectiveness study. Participants were block randomized by ICH location: anterior basal ganglia or lobar, and index Glasgow Coma Score to early ICH MIPS evacuation within 24 hours of last-known normal plus standard guideline-based management versus standard medical management alone. The goal of the trial was to determine if MIPS evacuation results in improved outcomes.
The abstract, authored by Gustavo Pradilla, Jonathan J. Ratcliff, Alex J. Hall, Benjamin R. Saville, Jason W. Allen, Michael Frankel, David W. Wright, Daniel L. Barrow, and for the ENRICH Investigators, will be presented by Dr. Pradilla. Dr. Pradilla is an associate professor of neurosurgery at the Emory University School of Medicine, he serves as chief of the neurosurgery service at Grady Memorial Hospital and is the co-director of the Emory Skull Base Surgery Center.
The Plenary Session l will begin at 8:30 am and continue until the closing of the session at 12:30 pm. The session will be located in the AANS Exhibit Hall and moderated by Michael P. Steinmetz and Babu Welch.
About the 2023 AANS Annual Scientific Meeting:
From April 21-24, 2023, in in Los Angeles, California, neurosurgeons, neurosurgical residents, medical students, neuroscience nurses, clinical specialists, physician assistants, allied health professionals and other medical professionals will join together for the 2023 AANS Annual Scientific Meeting. The annual meeting is the largest gathering of neurosurgeons in the nation, with an emphasis on the field’s latest research and technological advances. The scientific presentations scheduled for the 2023 event represent cutting-edge examples of the incredible developments taking place within the field of neurosurgery.
About the AANS:
Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 13,000 members worldwide. The AANS promotes the highest quality of patient care and advances the specialty of neurological surgery. Fellows of the AANS are board-certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons of Canada or the Mexican Council of Neurological Surgery, A.C. Neurosurgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the spinal column, spinal cord, brain, nervous system and peripheral nerves.
For more information, visit www.AANS.org.